RxDoctor Payments Data

Aline Studstill

Family · Ahoskie, NCNPI 1972137040

Payments from drug & device makers

$4,483in general payments, 2019–2025

Across 253 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$712
  • Harmony Biosciences LLC$669
  • AbbVie$529
  • Takeda Pharmaceuticals U.S.A., Inc.$382
  • Otsuka America Pharmaceutical, Inc.$304
  • Corium, LLC$248
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$4,33897%
  • Education$1453%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,483 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl22$33,696
TrintellixVortioxetine Hydrobromide19$13,196
Aripiprazole27$2,880
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine14$782
Duloxetine Hcl14$615
Alprazolam ErAlprazolam17$329
Gabapentin27$266
Buspirone Hcl19$262
Trazodone Hcl27$235
Quetiapine Fumarate16$199
Eszopiclone23$170
Clonazepam16$115
Risperidone18$93
Escitalopram Oxalate11$90
Lorazepam36$60

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$529$33,69622 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$382$13,19619 claims
Almatica Pharma LLCSertraline Hcl$84$2814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.

Other family in Ahoskie

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →